| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/12/2011 | WO2010146420A3 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites |
| 05/12/2011 | WO2010108245A3 Use of leishmania antigens in a diagnostic method, vaccine and therapy for leishmaniasis |
| 05/12/2011 | WO2010065969A8 Sparc binding scfcs |
| 05/12/2011 | US20110113497 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 05/12/2011 | US20110113495 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad) |
| 05/12/2011 | US20110112281 Cytotoxic composition |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112279 Compositions and Methods Relating to STOP-1 |
| 05/12/2011 | US20110112276 Mutated immunoglobulin-binding protein |
| 05/12/2011 | US20110112177 Human G-Protein Coupled Receptor (HETGQ23) |
| 05/12/2011 | US20110112037 Crystal structure |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111464 Methods and compositions for cloning nucleic acid molecules |
| 05/12/2011 | US20110111440 Elisa kit for detecting lincomycin |
| 05/12/2011 | US20110111427 Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarker |
| 05/12/2011 | US20110111424 Analysis of ubiquitinated polypeptides |
| 05/12/2011 | US20110111408 Methods and composition for secretion of heterologous polypeptides |
| 05/12/2011 | US20110111406 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 05/12/2011 | US20110111391 Newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110110966 Novel immunogenic proteins of leptospira |
| 05/12/2011 | US20110110963 Gene encoding labyrinthin, a marker for cancer |
| 05/12/2011 | US20110110959 Anti-p2x7 peptides and epitopes |
| 05/12/2011 | US20110110956 Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110954 Anthrax compositions and methods of use and production |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110949 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
| 05/12/2011 | US20110110947 Viral chemokine-antigen fusion proteins |
| 05/12/2011 | US20110110945 Immunoglobulin Fusion Proteins and Methods of Making |
| 05/12/2011 | US20110110944 Anti-alk1 antibodies and uses thereof |
| 05/12/2011 | US20110110943 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110942 Method of promoting dendritic spine density |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110936 Anti-gcc antibody molecules and related compositions and methods |
| 05/12/2011 | US20110110935 Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS |
| 05/12/2011 | US20110110934 Treatment of uveitis |
| 05/12/2011 | US20110110929 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110857 Mutant forms of chlamydia htra |
| 05/12/2011 | US20110110854 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
| 05/12/2011 | CA2816437A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | CA2780221A1 Methods for affinity maturation-based antibody optimization |
| 05/12/2011 | CA2780216A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| 05/12/2011 | CA2780143A1 Methods and composition for secretion of heterologous polypeptides |
| 05/12/2011 | CA2780130A1 Treating basal-like genotype cancers |
| 05/12/2011 | CA2779526A1 Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779396A1 Plants with improved nitrogen utilization and stress tolerance |
| 05/12/2011 | CA2779384A1 Engineered anti-tslp antibody |
| 05/12/2011 | CA2778810A1 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
| 05/12/2011 | CA2778552A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | CA2778203A1 Glycosylated repeat-motif-molecule conjugates |
| 05/12/2011 | CA2778112A1 Human il-23 antigen binding proteins |
| 05/12/2011 | CA2776563A1 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/11/2011 | EP2320437A1 Temperature-responsive magnetic fine grains capable of freeze drying |
| 05/11/2011 | EP2320233A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 05/11/2011 | EP2319931A1 Extracellular matrix-binding proteins from staphylococcus aureus |
| 05/11/2011 | EP2319930A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 05/11/2011 | EP2319929A1 IL-1 related polypeptides |
| 05/11/2011 | EP2319924A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 05/11/2011 | EP2319921A1 Novel protease and use thereof |
| 05/11/2011 | EP2319919A1 Nitrilases |
| 05/11/2011 | EP2319871A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319869A1 ANTIBODY AGAINST OXIDIZED LDL/ß²GPI COMPLEX AND USE OF THE SAME |
| 05/11/2011 | EP2319868A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/11/2011 | EP2319867A1 Human monoclonal nicotine specific antibodies |
| 05/11/2011 | EP2319866A2 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 05/11/2011 | EP2319861A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 05/11/2011 | EP2319536A1 Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
| 05/11/2011 | EP2319535A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319524A1 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 05/11/2011 | EP2319301A2 Transgenic animals bearing human Ig lambda light chain genes |
| 05/11/2011 | EP2318842A1 Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways |
| 05/11/2011 | EP2318548A2 Methods and systems for predicting response of cells to a therapeutic agent |
| 05/11/2011 | EP2318442A1 Treatment of autoimmune and inflammatory disease |
| 05/11/2011 | EP2318441A2 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 05/11/2011 | EP2318440A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |
| 05/11/2011 | EP2318439A2 Methods of altering peripheral b cell populations and uses thereof |
| 05/11/2011 | EP2318438A1 Anti-p2x7 peptiden und epitopen |
| 05/11/2011 | EP2318437A2 Method for treating multiple sclerosis patients with anti-il2r antibodies |
| 05/11/2011 | EP2318436A1 Variant domain antibodies |
| 05/11/2011 | EP2318048A1 Structural variants of antibodies for improved therapeutic characteristics |
| 05/11/2011 | EP2318041A1 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 05/11/2011 | EP1996716B1 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 05/11/2011 | EP1774037B1 Assays and methods using biomarkers |
| 05/11/2011 | EP1678209B1 Antibodies to nik, their preparation and use |
| 05/11/2011 | EP1530580B1 Chimeric gm-csf antibodies |
| 05/11/2011 | EP1449850B9 Human cdr-grafted antibodies and antibody fragments thereof |
| 05/11/2011 | CN1942585B Nucleic acid construct containing full-length genome of human hepatitis c virus, method for nucleic acid construct transferring into recombinant full-length virus genome replicative cell and method of producing hepatitis C virus particle |
| 05/11/2011 | CN1856571B Method for linking sequences of interest |
| 05/11/2011 | CN1688695B New dendritic cell co stimulatory molecules |
| 05/11/2011 | CN102057277A Detection of cannabis use |
| 05/11/2011 | CN102057272A Novel compositions and methods for the treatment of immune related diseases |